Evaluating futility of a binary clinical endpoint using early read-outs

被引:6
作者
Van Lancker, Kelly [1 ]
Vandebosch, An [2 ]
Vansteelandt, Stijn [1 ,3 ]
De Ridder, Filip [2 ]
机构
[1] Univ Ghent, Dept Appl Math Comp Sci & Stat, B-9000 Ghent, Belgium
[2] Janssen Pharmaceut NV, Janssen R&D, Beerse, Belgium
[3] London Sch Hyg & Trop Med, Dept Med Stat, London, England
关键词
biomarkers; conditional power; futility; interim analysis; LONG-TERM; TRIALS; RESPONSES;
D O I
10.1002/sim.8366
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Interim analyses are routinely used to monitor accumulating data in clinical trials. When the objective of the interim analysis is to stop the trial if the trial is deemed futile, it must ideally be conducted as early as possible. In trials where the clinical endpoint of interest is only observed after a long follow-up, many enrolled patients may therefore have no information on the primary endpoint available at the time of the interim analysis. To facilitate earlier decision-making, one may incorporate early response data that are predictive for the primary endpoint (eg, an assessment of the primary endpoint at an earlier time) in the interim analysis. Most attention so far has been given to the development of interim test statistics that include such short-term endpoints, but not to decision procedures. Existing tests moreover perform poorly when the information is scarce, eg, due to rare events, when the cohort of patients with observed primary endpoint data is small, or when the short-term endpoint is a strong but imperfect predictor. In view of this, we develop an interim decision procedure based on the conditional power approach that utilizes the short-term and long-term binary endpoints in a framework that is expected to provide reliable inferences, even when the primary endpoint is only available for a few patients, and has the added advantage that it allows the use of historical information. The operational characteristics of the proposed procedure are evaluated for the phase III clinical trial that motivated this approach, using simulation studies.
引用
收藏
页码:5361 / 5375
页数:15
相关论文
共 29 条
  • [1] Simple and effective confidence intervals for proportions and differences of proportions result from adding two successes and two failures
    Agresti, A
    Caffo, B
    [J]. AMERICAN STATISTICIAN, 2000, 54 (04) : 280 - 288
  • [2] [Anonymous], 2015, FUNDAMENTALS BIOSTAT
  • [3] Futility approaches to interim monitoring by data monitoring committees
    DeMets, David L.
    [J]. CLINICAL TRIALS, 2006, 3 (06) : 522 - 529
  • [4] Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
    Diacon, Andreas H.
    Pym, Alexander
    Grobusch, Martin P.
    de los Rios, Jorge M.
    Gotuzzo, Eduardo
    Vasilyeva, Irina
    Leimane, Vaira
    Andries, Koen
    Bakare, Nyasha
    De Marez, Tine
    Haxaire-Theeuwes, Myriam
    Lounis, Nacer
    Meyvisch, Paul
    De Paepe, Els
    van Heeswijk, Rolf P. G.
    Dannemann, Brian
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (08) : 723 - 732
  • [5] A general inefficacy interim monitoring rule for randomized clinical trials
    Freidlin, Boris
    Korn, Edward L.
    Gray, Robert
    [J]. CLINICAL TRIALS, 2010, 7 (03) : 197 - 208
  • [6] Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: An application in multiple sclerosis
    Friede, T.
    Parsons, N.
    Stallard, N.
    Todd, S.
    Marquez, E. Valdes
    Chataway, J.
    Nicholas, R.
    [J]. STATISTICS IN MEDICINE, 2011, 30 (13) : 1528 - 1540
  • [7] Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes
    Galbraith, S
    Marschner, IC
    [J]. STATISTICS IN MEDICINE, 2003, 22 (11) : 1787 - 1805
  • [8] AN AID TO DATA MONITORING IN LONG-TERM CLINICAL-TRIALS
    HALPERIN, M
    LAN, KKG
    WARE, JH
    JOHNSON, NJ
    DEMETS, DL
    [J]. CONTROLLED CLINICAL TRIALS, 1982, 3 (04): : 311 - 323
  • [9] Group sequential tests for delayed responses
    Hampson, Lisa V.
    Jennison, Christopher
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 2013, 75 (01) : 3 - 39
  • [10] Two-stage phase II oncology designs using short-term endpoints for early stopping
    Kunz, Cornelia U.
    Wason, James M. S.
    Kieser, Meinhard
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2017, 26 (04) : 1671 - 1683